Kathleen Boyle, Ph.D.
Chair of the Math and Science Division
Assistant Professor
Email: boylek@mtmary.edu
Phone: (414) 930-3528
Office: GC301 Gerhardinger Hall
Education
- Ph.D. in Medical Microbiology & Immunology, University of Wisconsin-Madison, 1998
- B.S. in Microbiology, University of Wisconsin –LaCrosse, 1990
Publications
- Professional Development in Unlearning Racism to Increase Capacity for Inclusion of All Students (with Diener L, Barry M, Baylor A, Anderson J, Barbosa G, Bell C, Boyle KA, End L, Homan C, Kraemer-Smothers M, Serros S, and C Bailey). Journal of Faculty Development. 2025. Manuscript in preparation.
- Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression (with Abu Eid M, McAllister D, McOlash L, Cleland Harwig M, Cheng G, Drouilard D, Boyle K, Zielonka J, Johnson B, Hill RB, Kalyanaraman B, and M Dwinell) ISciences. May 25;24(6):102653. eCollection 2021 Jun 25. PMID: 34189432
- Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells (with Cheng G, Hardy M, Zielonka J, Weh K, Zielonka M, Boyle K, Abu Eid M, McAlister D, Bennett B, Kresty L, Dwinell MB, and B Kalyanaraman) 2020. Cancer Treat Res Commun. PMID 32987287 PMCID PMC7883397
Requested Editorial
- Boyle KA and MB Dwinell. GEMMs are a gem when it comes to defining the role of HIF2alpha in mucinous cystic neoplasms. Editorial in Cell Mol Gastroenterol Hepatol. 2017 Dec 8;5(2):165-166. PMID 29693045 PMCID: PMC5904046.
Book Chapter
- Boyle KA, James MA, Tsai S, Evans DB and MB Dwinell. Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications. Pancreatic Cancer. Neoptolemos, Urrutia, Abbruzzese, Büchler (eds) Springer. 2017 Pgs. 1-28.
External Grant Funding
- Primary investigator National Science Foundation (NSF) S- STEM Award: 2030723 2021 – 2026 ($999,743)
- Co-primary investigator NSF S-STEM Award: 1644003 2017 – 2023 ($649,779)